SMTL ID : 4b05.1

Preclinical characterization of AZD3839, a novel clinical candidate BACE1 inhibitor for the treatment of Alzheimer Disease

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.80 Å
Oligo State
monomer
Ligands
5 x ACT: ACETATE ION(Non-functional Binders)
1 x NA: SODIUM ION(Non-functional Binders)
1 x 32D: (1S)-1-[2-(difluoromethyl)pyridin-4-yl]-4-fluoro-1-(3-pyrimidin-5-ylphenyl)-1H-isoindol-3-amine(Non-covalent)
Links
RCSB   PDBe   PDBj   PDBsum   CATH   PLIP
Citation
Jeppsson, F. et al., Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease. J. Biol. Chem. (2012)
Peptides
BETA-SECRETASE 1: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

BETA-SECRETASE 1

Related Entries With Identical Sequence

1w50.1 | 1w51.1 | 3rsv.1 | 3rsx.1 | 3rth.1 | 3rtm.1 | 3rtn.1 | 3ru1.1 | 3rvi.1 | 4acu.1 | 4acx.1 | 4azy.1 | 4b00.1 | 4dh6.1 | 4di2.1 | 4di2.2 | 4di2.3 | 4dus.1 | 4fri.1 | 4frj.1 | 4frk.1 | 4ke0.1 | 4ke0.2 | 4ke0.3 | 4ke1.1 | 4rcd.1 | 4rce.1 | 4rcf.1 | 4wtu.1 | 4xkx.1  more...